Wilfactin

Wilfactin is a human von Willebrand factor concentrate used to manage bleeding disorders like von Willebrand disease. This intravenous therapy supports blood clotting by replacing missing or deficient clotting proteins. Ideal for patients requiring reliable clotting support. Short-term use addresses acute bleeding episodes effectively.

Wilfactin is primarily used to treat and prevent bleeding in patients with von Willebrand disease, a condition where blood does not clot properly. It works by replacing the missing von Willebrand factor, which is essential for normal blood clotting. This medication is often prescribed for routine prophylaxis or during surgical procedures to minimize bleeding risk. Patients with mild to severe forms of the disease may benefit from its clotting support.

After administration, Wilfactin helps restore normal clotting function by increasing von Willebrand factor levels in the bloodstream. Patients may notice reduced bleeding episodes and improved clotting stability over time. The effects typically begin shortly after infusion and can last for several days, depending on individual response. Consistent use helps maintain steady clotting factor levels.

Wilfactin should be handled with care to avoid contamination or improper administration. Always use sterile techniques when preparing and injecting the solution. Patients should be monitored for signs of allergic reactions or infusion-related issues during and after treatment. Store the product as directed, typically in a cool, dry place away from direct light.

Wilfactin may interact with medications that affect blood clotting, such as anticoagulants or antiplatelet drugs, potentially altering their effects. Patients should inform their healthcare provider about all current medications before starting Wilfactin. Alcohol and certain herbal supplements may also influence clotting function and should be used cautiously. Always consult a healthcare professional for personalized advice.